[{"Assets_0_Q3_USD":724633000.0,"CIK":"1595893","CommonStockSharesConverted_0_Q3_shares":42213364.0,"CommonStockSharesOutstanding_0_Q3_shares":42213364.0,"Country":"United States","EarningsPerShareBasic_1_Q3_USD":-0.42,"EarningsPerShareBasic_3_Q3_USD":-2.82,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"1579986704.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-49420000.0,"NetIncomeLossConverted_1_Q3_USD":-17705000.0,"NetIncomeLossConverted_3_Q3_USD":-109916000.0,"OfficialName":"Turning Point Therapeutics Inc. Common Stock","RevenuesConverted_1_Q3_USD":25000000.0,"RevenuesConverted_3_Q3_USD":25000000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquity_0_Q3_USD":701588000.0,"Ticker":"TPTX","filed":"20201112","footnote":"nan","form":"10-Q","fp":"Q3","fy":"2020.0","name":"TURNING POINT THERAPEUTICS, INC.","period":"20200930","qtrs":"1","uom":"USD"}]